Liaoning Chengda Biotechnology Co Ltd
SSE:688739

Watchlist Manager
Liaoning Chengda Biotechnology Co Ltd Logo
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Watchlist
Price: 28.75 CNY 0.45%
Market Cap: 5.3B CNY
Have any thoughts about
Liaoning Chengda Biotechnology Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Liaoning Chengda Biotechnology Co Ltd

Wall Street analysts forecast Liaoning Chengda Biotechnology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Liaoning Chengda Biotechnology Co Ltd is 40.8 CNY with a low forecast of 40.4 CNY and a high forecast of 42 CNY.

Lowest
Price Target
40.4 CNY
41% Upside
Average
Price Target
40.8 CNY
42% Upside
Highest
Price Target
42 CNY
46% Upside
Liaoning Chengda Biotechnology Co Ltd Competitors:
Price Targets
688192
Dizal Jiangsu Pharmaceutical Co Ltd
15% Upside
OPK
OPKO Health Inc
151% Upside
INCY
Incyte Corp
6% Downside
BCRX
BioCryst Pharmaceuticals Inc
89% Upside
300896
Imeik Technology Development Co Ltd
26% Upside
PROB
Probi AB
22% Downside
DNLI
Denali Therapeutics Inc
39% Upside
MAB
Mabion SA
34% Upside

Revenue
Forecast

Revenue Estimate
Liaoning Chengda Biotechnology Co Ltd

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 6%.

7%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Liaoning Chengda Biotechnology Co Ltd

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is 6%.

1%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Liaoning Chengda Biotechnology Co Ltd

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's net income is 1%. The projected CAGR for the next 3 years is -21%.

1%
Past Growth
-21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Liaoning Chengda Biotechnology Co Ltd's stock price target?
Price Target
40.8 CNY

According to Wall Street analysts, the average 1-year price target for Liaoning Chengda Biotechnology Co Ltd is 40.8 CNY with a low forecast of 40.4 CNY and a high forecast of 42 CNY.

What is Liaoning Chengda Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 6%.

What is Liaoning Chengda Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
6%

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is 6%.

What is Liaoning Chengda Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
-21%

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's net income is 1%. The projected CAGR for the next 3 years is -21%.

Back to Top